REGENEREX PHARMA, INC. (RGPX) › Total LiabilitiesREGENEREX PHARMA, INC. (RGPX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2012: $815.1K2013: $1.75M2014: $799.2K2018: $336.2K2019: $475.3K2020: $740.4K2021: $845.5K2022: $1.00M2023: $1.13M2024: $4.83M2025: $5.42M$5.42M2012Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$5.42M+12.2%2024$4.83M+327.5%2023$1.13M+12.8%2022$1.00M+18.4%2021$845.5K+14.2%2020$740.4K+55.8%2019$475.3K+41.4%2018$336.2K—2014$799.2K-54.4%2013$1.75M+114.8%2012$815.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share